Source: Annual Congress 2012 - COPD comorbidities II



Rating:

Share or cite this content

Citations should be made in the following way:
B. Açikmese, G. Çamsari, A. Gür, N.D. Bakan, G. Özkan, P. Güven (Istanbul, Turkey). The association between pulmonary arterial hypertension secondary to chronic lung disease and serum asymmetric dimethylarginine levels. Eur Respir J 2012; 40: Suppl. 56, 557

Member's Comments

No comment yet.

Related content which might interest you: C-reactive protein and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease with pulmonary arterial hypertension Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010 Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 L-arginine plasma levels correlate with severity of primary pulmonary hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 560s Year: 2004 Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia Source: International Congress 2017 – PAH and CTEPH Year: 2017 Fibrinogen plasma levels and disease severity in pulmonary artery hypertension Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Elevated levels of adenosine in the lungs lead to chronic lung injury and pulmonary hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Single arterial occlusion to locate resistance in patients with pulmonary hypertension Source: Eur Respir J 2003; 21: 31-36 Year: 2003 The levels of serum malonyldialhyde and paraoxonase in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Asymmetric dimethylarginine (ADMA) to monitor treatments of pulmonary hypertension Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease? Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 The link between systemic inflammation and pulmonary hypertension in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005 Asymmetric dimethylarginine, a biomarker for the effects of drug therapy in pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers Year: 2012 Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension and their relationship with right ventricular structure and function Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Inflammatory cell accumulation in pulmonary arteries is associated with systemic inflammation in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Serum osteoprotegerin expression correlates with disease progression and severity in rodent models of pulmonary arterial hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Changing serum cytokines levels in patients with idiopathic pulmonary arterial hypertension treated with bosentan Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura Year: 2012 Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009